Excessive risk of cancer and in particular lymphoid malignancy in myasthenia gravis patients: A population-based cohort study

Neuromuscular Disorders

Volumn 24, Issue 3, 2014, Pages 245-249

  Yeh, Jiann Horng ^a,b   Lin, Che Chen ^c   Chen, Yen Kung ^a,b   Sung, Fung Chang ^c,d   Chiu, Hou Chang ^a,b   Kao, Chia Hung ^c,d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Leukemia; Lymphoma; Myasthenia gravis; Thymic carcinoma; Thymus cancer

Indexed keywords

LEUKEMIA; LYMPHOMA; MYASTHENIA GRAVIS; THYMIC CARCINOMA; THYMUS CANCER;

ADULT; COHORT STUDIES; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RISK FACTORS; TAIWAN; THYMUS NEOPLASMS;

EID: 84894237845     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2013.11.007     Document Type: Article

References (12)

1. Meriggioli M.N., Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009, 8:475-490.
2. Citterio A., Beghi E., Millul A., et al. Risk factors for tumor occurrence in patients with myasthenia gravis. J Neurol 2009, 256:1221-1227.
3. Levin N., Abramsky O., Lossos A., et al. Extrathymic malignancies in patients with myasthenia gravis. J Neurol Sci 2005, 237:39-43.
4. Owe J.F., Cvancarova M., Romi F., et al. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci 2010, 290:66-69.
5. Monden Y., Uyama T., Kimura S., et al. Extrathymic malignancy in patients with myasthenia gravis. Eur J Cancer 1991, 27:745-747.
6. Evoli A., Batocchi A.P., Tonali P., et al. Risk of cancer in patients with myasthenia gravis. Ann NY Acad Sci 1998, 841:742-745.
7. Wakata N., Sugimoto H., Nomoto N., et al. Extrathymic tumors in patients with myasthenia gravis: a 35-year retrospective study. Neurologist 2006, 12:53-55.
8. Liu C.J., Chang Y.S., Teng C.J., et al. Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study. Eur J Neurol 2012, 19:746-751.
9. Fujimaki K., Takasaki H., Koharazawa H., et al. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia. Leuk Lymphoma 2005, 46:1101-1102.
10. Bowen J.D., Kidd P. Myasthenia gravis associated with T helper cell lymphoma. Neurology 1987, 37:1405-1408.
11. Rezania K., Soliven B., Baron J., et al. Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leuk Lymphoma 2012, 53:371-380.
12. Zintzaras E., Voulgarelis M., Moutsopoulos H.M. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005, 165:2337-2344.